BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Olagunju A, Yamani N, Kenny D, Mookadam M, Mookadam F, Unzek S. Potential for sodium-glucose cotransporter-2 inhibitors in the management of metabolic syndrome: A systematic review and meta-analysis. World J Cardiol 2022; 14(11): 599-616 [PMID: 36483765 DOI: 10.4330/wjc.v14.i11.599]
URL: https://www.wjgnet.com/1949-8462/full/v14/i11/599.htm
Number Citing Articles
1
І. М. Кліщ. МЕТАБОЛІЧНИЙ СИНДРОМ: ПОГЛЯД НА ПРОБЛЕМУЗдобутки клінічної і експериментальної медицини 2024; (1): 17 doi: 10.11603/1811-2471.2024.v.i1.14523
2
Maria Cristina Costa de Almeida, Marildes Luiza Castro, Larissa Espíndola, Luciana Nicolau Aranha, Thaís Salim, Gláucia Maria Moraes de Oliveira. One Size Does Not Fit All: The Need to Rethink the Metabolic Syndrome in WomenInternational Journal of Cardiovascular Sciences 2023; 36 doi: 10.36660/ijcs.20230101
3
Lubna Islam, Dhanya Jose, Mohammed Alkhalifah, Dania Blaibel, Vishnu Chandrabalan, Joseph M Pappachan. Comparative efficacy of sodium glucose cotransporter-2 inhibitors in the management of type 2 diabetes mellitus: A real-world experienceWorld Journal of Diabetes 2024; 15(3): 463-474 doi: 10.4239/wjd.v15.i3.463